Advertisement
U.S. Markets open in 5 hrs 52 mins
S&P Futures
5,955.50 +16.75 (+0.28%) Dow Futures
43,538.00 +138.00 (+0.32%) Nasdaq Futures
20,831.25 +63.50 (+0.31%) Russell 2000 Futures
2,341.30 +7.20 (+0.31%) Crude Oil
69.72 +0.33 (+0.48%) Gold
2,625.70 -5.30 (-0.20%)
ClearPoint Neuro, Inc. (CLPT)
NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Follow
At close: 04:00PM EST
After hours:
| Previous Close | 10.74 |
| Open | 10.68 |
| Bid | 10.89 x 400 |
| Ask | 10.99 x 300 |
| Day's Range | 10.61 - 11.15 |
| 52 Week Range | 5.11 - 14.13 |
| Volume | |
| Avg. Volume | 216,130 |
| Market Cap | 302.604M |
| Beta (5Y Monthly) | 1.11 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.69 |
| Earnings Date | Jan 06, 2025 - Jan 10, 2025 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 16.33 |
ACCESSWIREClearPoint Neuro Announces FDA De Novo Marketing Authorization of SmartFlow Cannula for Direct Delivery of Gene Therapy to the Brain
Only Device Approved to Deliver First Disease-Modifying Treatment for AADC Deficiency in the United States SOLANA BEACH, CA / ACCESSWIRE / November 13, 2024 / ClearPoint Neuro, Inc. (Nasdaq:CLPT) (the "Company"), a global therapy-enabling platform ...
Simply Wall St.The ClearPoint Neuro, Inc. (NASDAQ:CLPT) Third-Quarter Results Are Out And Analysts Have Published New Forecasts
Last week, you might have seen that ClearPoint Neuro, Inc. ( NASDAQ:CLPT ) released its third-quarter result to the...
Advertisement
Advertisement
Advertisement
© 2024 Yahoo. All rights reserved.